ENVXW Insider Exercise: Chakravarthy Acquires 9,513 Shares via Warrants

Rhea-AI Filing Summary

Enovix Corp (ENVX) reporting person Arthi Chakravarthy, Chief Legal Officer, exercised publicly-traded warrants on 08/27/2025 to acquire 9,513 shares of common stock at an exercise price of $8.75 per share. The warrants were distributed on July 21, 2025 and each entitled the holder to purchase one share at $8.75. Following the transaction the reporting person beneficially owned 437,954 shares, which includes 333,800 shares issuable upon settlement of RSUs. The warrants had an original expiration that was accelerated when an early expiration price condition was met on 08/28/2025, making the warrants cease to be exercisable after 5:00 p.m. ET on 08/29/2025.

Insights

Financial Analyst

TL;DR: Insider exercised warrants to acquire 9,513 shares at $8.75; holdings now include substantial RSU-based shares.

The transaction is a routine exercise of publicly-distributed warrants, resulting in a modest increase in the reporting person’s direct share count. The filing discloses 9,513 shares acquired via warrant exercise and total beneficial ownership of 437,954 shares, inclusive of 333,800 RSU-settling shares. There is no earnings or revenue information in this Form 4, and no indication of sales or transfers of other holdings. For investors, this is a disclosure of insider position change rather than a material corporate event.

Corporate Governance Expert

TL;DR: Transaction documents and timing are disclosed clearly; early-termination condition accelerated warrant expiry.

The Form 4 provides the required compliance details: reporting person identity and officer title, transaction date, exercise price, number of shares acquired, and the impact on beneficial ownership. It also explains the acceleration of the warrant expiration following satisfaction of an early expiration price condition on 08/28/2025. The disclosure appears complete for Section 16 reporting purposes and contains the signer’s attestation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chakravarthy Arthi

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W. WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		X		9,513(1)	A	$8.75(1)	437,954(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (Right to Buy)	$8.75	08/27/2025		X			9,513(1)	07/21/2025	08/29/2025(3)	Common Stock, par value $0.0001	9,513	$0	0	D

Explanation of Responses:

1. Reflects shares issued upon the exercise of publicly-traded warrants (the "Warrants") by the Reporting Person. The Warrants were distributed by the Issuer on July 21, 2025, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement").

2. Includes 333,800 shares issuable upon the settlement of RSUs granted to the Reporting Person.

3. In accordance with the Warrant Agreement, the expiration of the Warrants was subject to acceleration upon the satisfaction of the early expiration price condition. On August 28, 2025, the early expiration price condition was met and the expiration date for the Warrants was accelerated to August 29, 2025. The Warrants was ceased to be exercisable as of 5:00 p.m. New York City time on August 29, 2025.

Remarks:

	/s/ Arthi Chakravarthy	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Arthi Chakravarthy report on Form 4 for ENVXW?

The filing reports the exercise of publicly-distributed warrants on 08/27/2025 to acquire 9,513 shares at an exercise price of $8.75 per share.

How many shares does the reporting person beneficially own after the transaction?

Following the reported transaction, the reporting person beneficially owned 437,954 shares, which includes 333,800 shares issuable upon settlement of RSUs.

When were the warrants distributed and what are their key terms?

The warrants were distributed by the issuer on July 21, 2025; each warrant entitles the holder to purchase one share at $8.75 per share under the Warrant Agreement.

Why did the warrant expiration change?

The Warrant Agreement provided for acceleration upon satisfying an early expiration price condition; that condition was met on 08/28/2025, accelerating the expiration to 08/29/2025 and making the warrants non-exercisable after 5:00 p.m. ET on that date.

What is the reporting person’s title at Enovix?

The Form 4 lists the reporting person, Arthi Chakravarthy, as the company’s Chief Legal Officer.